89bio Newsroom

Evercore Maintains 89bio(ETNB.US) With Buy Rating, Maintains Target Price $33

Futu NewsNov 11 21:31

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), 89bio (ETNB) and Ardent Health Partners, Inc. (ARDT)

TipRanksNov 11 21:17

H.C. Wainwright Maintains 89bio(ETNB.US) With Buy Rating, Maintains Target Price $29

Futu NewsNov 11 20:34

HC Wainwright & Co. Reiterates Buy on 89bio, Maintains $29 Price Target

BenzingaNov 11 20:26

89bio Analyst Ratings

BenzingaNov 9 01:35

Raymond James Maintains Strong Buy on 89bio, Lowers Price Target to $49

BenzingaNov 9 01:35

RBC Capital Maintains 89bio(ETNB.US) With Hold Rating, Maintains Target Price $12

Futu NewsNov 8 20:35

89bio (ETNB) Gets a Hold From RBC Capital

TipRanksNov 8 20:09

89bio Analyst Ratings

BenzingaSep 21 00:15

Cantor Fitzgerald Reiterates Overweight on 89bio, Maintains $29 Price Target

BenzingaSep 21 00:15

Leerink Partners Maintains 89bio(ETNB.US) With Buy Rating, Maintains Target Price $34

Futu NewsAug 7 13:32

Buy Rating Affirmed for 89bio: Promising Pegozafermin Trials and Regulatory Confidence

TipRanksAug 7 13:29

89bio Price Target Raised to $53.00/Share From $50.00 by Raymond James

Dow JonesAug 7 01:21

RBC Capital Maintains Sector Perform on 89bio, Lowers Price Target to $12

BenzingaAug 6 20:45

Evercore Maintains 89bio(ETNB.US) With Buy Rating, Maintains Target Price $33

Futu NewsAug 6 20:34

RBC Capital Maintains 89bio(ETNB.US) With Hold Rating, Cuts Target Price to $12

Futu NewsAug 6 19:31

89bio (ETNB) Receives a Hold From RBC Capital

TipRanksAug 6 19:05

HC Wainwright & Co. Reiterates Buy on 89bio, Maintains $29 Price Target

BenzingaAug 6 18:43

89bio Analyst Ratings

BenzingaAug 6 18:43

H.C. Wainwright Maintains 89bio(ETNB.US) With Buy Rating, Maintains Target Price $29

Futu NewsAug 6 18:31